D-dimers (DD) in CVST

Abstract

Objective: We were interested in further confirming whether D-dimers (DD) are indeed elevated in cerebral venous sinus thrombosis (CVST) as reported in those studies. Methods: CVST patients who had a plasma D-dimer test (139 cases) were included and divided into two groups: elevated D-dimer group (EDG) (>0.5 μg/mL; 65 cases) and normal D-dimer group (NDG) (≤0.5 μg/mL; 74 cases). The two groups were compared in terms of demographic data, clinical manifestation, laboratory and imaging data, using inferential statistical methods. Results: The chi-squared and Fisher exact test showed that, compared to the NDG (74 cases), patients with elevated D-dimer levels were more likely to have a shorter symptom duration (SD) (30 ± 83.9 versus 90 ± 58.9 d, p = 0.003), more risk factors (75.4% versus 52.7%, p = 0.006), higher multiple venous sinus involvement (75.4% versus 59.5%, p = 0.037), increased fibrinogen (43.1% versus 18.9%, p = 0.037) and higher levels of blood glucose (18.3% versus 11%, p = 0.037). According to correlation analyses, D-dimer levels were positively correlated with number of venous sinuses involvement (NVS) (r = 0.321, p = 0.009) in the EDG. Multivariate logistic regression analysis showed that SD (OR, 0.025; 95% CI, 1.324–6.043; p = 0.000), NVS (OR, 1.573; 95% CI, 1.15–2.151; p = 0.005) and risk factors (OR, 3.321; 95% CI, 1.451–7.564; p = 0.004) were significantly different between the two groups. Conclusion: D-dimer is elevated in patients with acute/subacute CVST.

KEYWORDS:

• cerebral venous sinus thrombosis
• D-dimer
• symptom duration
• number of venous sinuses involvement
• blood glucose

Acknowledgements

My deepest gratitude goes to Tiane Luo (ShanXi Medical University) provided assistance in statistical analysis.

Declaration of Interest

The authors report no conflicts of interest.